TerminatedNCT03397446
Lisdexamfetamine for Adults With Eating disorders
Medication studyAges 18–55Canada
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- HalifaxSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 21, 2018
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 23
- Sponsor
- Aaron Keshen
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT03397446
- Official title
Show the full official title
A Feasibility Study to Evaluate Lisdexamfetamine Dimesylate (Vyvanse) in Adults With Bulimia Nervosa
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Halifax
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Aaron Keshen.
Does this study involve medication?
Yes. The study involves medication, including Lisdexamfetamine dimesylate.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as terminated.
